Myeloma & AL Amyloidosis: Why Early Diagnosis Matters and How Research Can Help

Event Description
Early diagnosis can make all the difference for multiple myeloma and AL amyloidosis patients, but delays are common. In this webinar, Dr. Nadine Abdallah will share findings from her HealthTree research, “AL Amyloidosis: Understanding the Clinical Prodrome and Delays in Diagnosis.” She’ll discuss how the study was conducted, key results, and why they matter to patients. Learn how you can help improve future research by participating in studies and surveys. A Patient Navigator, from HealthTree, will be available at the end of the webinar to answer any questions you have about HealthTree Cure Hub and how you can power lifesaving research. Don’t miss this important discussion!
Schedule & Agenda

Cynthia introduces the agenda of the event and featured speaker Dr. Nadine Abdallah

Cynthia introduces the agenda of the event and featured speaker Dr. Nadine Abdallah

Dr. Nadine Abdallah shares insights from her research and ways to support future studies

Dr. Nadine Abdallah shares insights from her research and ways to support future studies
Type your questions in the chat and we will answer them!
Type your questions in the chat and we will answer them!
Speakers & Moderators

Cynthia is a newborn ICU nurse by trade that has spent the last six years in the medical device industry educating nurses and doctors about devices that are new to their facility. In her spare time she enjoys hiking, traveling the world with her family, and creating Halloween animatronics for her annual front yard display. She has a passion for life-long learning and enjoys sharing what she learns with the people around her.

Dr. Nadine H. Abdallah is an Assistant Professor in the Division of Hematology at Mayo Clinic in Rochester, MN. Her research focuses on understanding the impact of frailty, body composition, and social determinants of health on outcomes of older patients with myeloma patients, with the aim of personalizing care. She studies physical, radiological, and laboratory biomarkers of frailty and both pharmacologic and behavioral interventions to improve fitness, treatment outcomes, and quality of life in patients with multiple myeloma. Her work also incorporates digital health technologies to increase clinical trial access and minimize patient burdens.
Join the Conversation
This event is part of the AL Amyloidosis group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org

Get the Latest Blood Cancer Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.